PHARMACOGENOMIC DRUG INTERACTION
Clinical trials for PHARMACOGENOMIC DRUG INTERACTION explained in plain language.
Never miss a new study
Get alerted when new PHARMACOGENOMIC DRUG INTERACTION trials appear
Sign up with your email to follow new studies for PHARMACOGENOMIC DRUG INTERACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene test before your next prescription could stop side effects
Knowledge-focused Recruiting nowThis study looks at whether giving patients a genetic test before they start certain common drugs can lower the chance of side effects like muscle pain, falls, or fainting. About 66 adults getting a first-time prescription for one of 39 drugs will be tested, and their doctors wil…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 00:31 UTC
-
DNA test aims to slash medication risks in seniors
Knowledge-focused Recruiting nowThis study looks at whether using a person's DNA to guide medication choices can reduce falls and other drug-related problems in older adults who take five or more medicines. About 1,000 people over age 65 who have had a fall will provide a cheek swab for DNA analysis. Half of th…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: NA • Sponsor: Florida Atlantic University • Aim: Knowledge-focused
Last updated May 17, 2026 00:30 UTC
-
Gene test before your next pill could save lives
Knowledge-focused Recruiting nowThis study looks at whether testing a person's genes before giving them a new medicine can prevent side effects and make treatments work better. About 2,000 adults in the hospital will give a cheek swab for gene testing. Half get results right away to guide their prescription, th…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: NA • Sponsor: NHS Greater Glasgow and Clyde • Aim: Knowledge-focused
Last updated May 17, 2026 00:28 UTC